BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

761 related articles for article (PubMed ID: 19527334)

  • 1. A lipohydroxyacid-containing shampoo improves scalp condition and quality of life in patients with seborrheic dermatitis and light-to-moderate scalp psoriasis.
    Seité S; Paries J; Reygagne P; Hamidou Z; Jouanique C; Perez-Pala G; Rougier A
    J Cosmet Dermatol; 2009 Jun; 8(2):108-13. PubMed ID: 19527334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized study comparing the efficacy and tolerance of a lipohydroxy acid shampoo to a ciclopiroxolamine shampoo in the treatment of scalp seborrheic dermatitis.
    Seite S; Rougier A; Talarico S
    J Cosmet Dermatol; 2009 Dec; 8(4):249-53. PubMed ID: 19958427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of a new ciclopiroxolamine/zinc pyrithione shampoo in scalp seborrheic dermatitis treatment.
    Lorette G; Ermosilla V
    Eur J Dermatol; 2006; 16(5):558-64. PubMed ID: 17101479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, investigator-masked clinical evaluation of the efficacy and safety of clobetasol propionate 0.05% shampoo and tar blend 1% shampoo in the treatment of moderate to severe scalp psoriasis.
    Griffiths CE; Finlay AY; Fleming CJ; Barker JN; Mizzi F; Arsonnaud S
    J Dermatolog Treat; 2006; 17(2):90-5. PubMed ID: 16766333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral) for the treatment of dandruff/seborrhoeic dermatitis.
    Squire RA; Goode K
    J Dermatolog Treat; 2002 Jun; 13(2):51-60. PubMed ID: 12060502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Iralfaris shampoo in the treatment of scalp psoriasis: a videodermoscopy evaluation prospective study in 70 patients.
    Rossi A; Pranteda G; Iorio A; Mari E; Milani M
    G Ital Dermatol Venereol; 2012 Dec; 147(6):625-30. PubMed ID: 23149708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of different concentrations of ciclopirox shampoo for the treatment of seborrheic dermatitis of the scalp: results of a randomized, double-blind, vehicle-controlled trial.
    Altmeyer P; Hoffmann K;
    Int J Dermatol; 2004 Jul; 43 Suppl 1():9-12. PubMed ID: 15271194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clobetasol propionate shampoo 0.05%: a new option to treat patients with moderate to severe scalp psoriasis.
    Jarratt M; Breneman D; Gottlieb AB; Poulin Y; Liu Y; Foley V
    J Drugs Dermatol; 2004; 3(4):367-73. PubMed ID: 15303780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale of frequency of use of ciclopirox 1% shampoo in the treatment of seborrheic dermatitis: results of a double-blind, placebo-controlled study comparing the efficacy of once, twice, and three times weekly usage.
    Abeck D;
    Int J Dermatol; 2004 Jul; 43 Suppl 1():13-6. PubMed ID: 15271195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolving role of therapeutic shampoos for targeting symptoms of inflammatory scalp disorders.
    Kircik L
    J Drugs Dermatol; 2010 Jan; 9(1):41-8. PubMed ID: 20120424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciclopirox shampoo for treating seborrheic dermatitis.
    Gupta AK; Bluhm R
    Skin Therapy Lett; 2004; 9(6):4-5. PubMed ID: 15334279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trial.
    Lebwohl M; Plott T
    Int J Dermatol; 2004 Jul; 43 Suppl 1():17-20. PubMed ID: 15271196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis.
    Ratnavel RC; Squire RA; Boorman GC
    J Dermatolog Treat; 2007; 18(2):88-96. PubMed ID: 17520465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dandruff/seborrhoeic dermatitis is characterized by an inflammatory genomic signature and possible immune dysfunction: transcriptional analysis of the condition and treatment effects of zinc pyrithione.
    Mills KJ; Hu P; Henry J; Tamura M; Tiesman JP; Xu J
    Br J Dermatol; 2012 Jun; 166 Suppl 2():33-40. PubMed ID: 22670617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical effectiveness and tolerance of climbazole containing dandruff shampoo in patients with seborrheic scalp eczema].
    Wigger-Alberti W; Kluge K; Elsner P
    Praxis (Bern 1994); 2001 Aug; 90(33):1346-9. PubMed ID: 11534318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does tachyphylaxis occur in long-term management of scalp seborrheic dermatitis with pyrithione zinc-based treatments?
    Schwartz JR; Rocchetta H; Asawanonda P; Luo F; Thomas JH
    Int J Dermatol; 2009 Jan; 48(1):79-85. PubMed ID: 19126058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of moderate scalp psoriasis.
    Poulin Y; Papp K; Bissonnette R; Barber K; Kerrouche N; Villemagne H;
    J Dermatolog Treat; 2010 May; 21(3):185-92. PubMed ID: 20131980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacies of topical agents for the treatment of seborrheic dermatitis of the scalp: a comparative study.
    Shin H; Kwon OS; Won CH; Kim BJ; Lee YW; Choe YB; Ahn KJ; Eun HC
    J Dermatol; 2009 Mar; 36(3):131-7. PubMed ID: 19335686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clobetasol propionate shampoo 0.05% in the treatment of seborrheic dermatitis of the scalp: results of a pilot study.
    Reygagne P; Poncet M; Sidou F; Soto P
    Cutis; 2007 May; 79(5):397-403. PubMed ID: 17569404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment and prophylaxis of seborrheic dermatitis of the scalp with antipityrosporal 1% ciclopirox shampoo.
    Shuster S; Meynadier J; Kerl H; Nolting S
    Arch Dermatol; 2005 Jan; 141(1):47-52. PubMed ID: 15655141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.